In breast cancer, chemotherapy activates the EZH2/STAT3 axis leading to the production of ExomiR-378a-3p and ExomiR-378d, resulting in chemotherapy-elicited, exosome-induced drug resistance (Yang et al., 2021). Here, STAT3 is linked to breast carcinoma.